Standout Papers

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional... 2004 2026 2011 2018 571
  1. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease (2004)
    Lemin Zheng, Marie‐Luise Brennan et al. Journal of Clinical Investigation
  2. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease (2004)
    Lemin Zheng, Marie-Luise Brennan et al. Journal of Clinical Investigation

Immediate Impact

1 by Nobel laureates 16 from Science/Nature 64 standout
Sub-graph 1 of 21

Citing Papers

Circadian alignment of early onset caloric restriction promotes longevity in male C57BL/6J mice
2022 StandoutScience
The changing landscape of atherosclerosis
2021 StandoutNature
2 intermediate papers

Works of Megan Settle being referenced

Atherosclerosis Susceptibility Loci Identified From a Strain Intercross of Apolipoprotein E–Deficient Mice via a High-Density Genome Scan
2005
Localization of Nitration and Chlorination Sites on Apolipoprotein A-I Catalyzed by Myeloperoxidase in Human Atheroma and Associated Oxidative Impairment in ABCA1-dependent Cholesterol Efflux from Macrophages
2004

Author Peers

Author Last Decade Papers Cites
Megan Settle 512 595 652 11 1.7k
Joellen Barnett 510 378 527 13 2.2k
Constanze Bergt 436 574 352 13 1.3k
Alan C. Wagner 592 444 925 23 2.0k
Annalisa Iezzi 323 459 394 19 1.8k
Naeimeh Kamranpour 401 230 534 11 1.4k
Manjula Chaddha 633 328 1003 28 1.9k
Greg P. Hough 253 293 559 7 1.4k
Veneracion G. Cabana 622 302 980 31 2.1k
Chang Yeop Han 531 261 418 18 1.6k
Mario Campagnola 507 702 289 24 1.8k

All Works

Loading papers...

Rankless by CCL
2026